Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine bolus plus continuous infusion for TAP block safety pilot
ACTRN12612000104853Phase 4Recruiting
- Sponsor
- Dr Sarika Kumar
- Start
- Oct 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ropivacaine in postoperative pain, sponsored by Dr Sarika Kumar. Primary endpoint: Total and free ropivacaine concentration at 48 hours. Started Oct 2011; status: recruiting.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ACTRN12612000104853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000104853.